Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 16.
doi: 10.1007/s11764-025-01795-4. Online ahead of print.

Late-onset epilepsy in survivors of childhood cancer outside the central nervous system: a study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study

Tina Gerbek  1 , Anna Sällfors Holmqvist  2 , Karen Markussen Linnet  3 , Camilla Pedersen  1 , Sofie de Fine Licht  1 , Jane Christensen  4 , Anja Krøyer  1 , Hanna Mogensen  5 , Maria Feychting  5 , Thomas Wiebe  2 , Lars Hjorth  2 , Yasmin Lassen-Ramshad  6 , Päivi M Lähteenmäki  7 , Catherine Rechnitzer  8 , Henrik Hasle  3 , Line Kenborg  9
Affiliations

Late-onset epilepsy in survivors of childhood cancer outside the central nervous system: a study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study

Tina Gerbek et al. J Cancer Surviv. .

Abstract

Purpose: Although epilepsy has been reported in survivors of childhood cancer outside the central nervous system (CNS), little evidence exists on risk factors for this late complication. Our study aimed to identify risk factors of late-onset epilepsy.

Methods: A case-cohort study was conducted within 5-year survivors of non-CNS childhood cancer from the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study, including 81 survivors diagnosed with late-onset epilepsy and a sub-cohort of 231 randomly selected survivors. Detailed treatment information was obtained from medical records. Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) were calculated to assess the association between treatment-related factors and epilepsy.

Results: Survivors of acute lymphoblastic leukemia (ALL) and other types of leukemia exhibited significantly higher IRRs for epilepsy compared to survivors of solid tumors (ALL: 4.4, 95% CI 2.2-8.5; other leukemia: 14.1, 95% CI 3.4-57.9). Relapse was associated with an increased IRR of epilepsy (3.5, 95% CI 1.5-8.6). Specifically, survivors of relapsed leukemia demonstrated a high IRR for epilepsy (11.4, 95% CI 3.5 - 37.3) compared to non-relapsed survivors. No association was found between epilepsy and bone marrow transplantation, radiotherapy, total body irradiation, or treatment with specific chemotherapeutic agents. Finally, survivors diagnosed after 1990 had a decreased IRR of epilepsy (0.4, 95% CI 0.2 - 0.8) compared to survivors diagnosed in 1970 - 1979.

Conclusion: Relapsed leukemia survivors were at increased risk for late-onset epilepsy.

Implications for cancer survivors: Awareness of the risk of epilepsy in leukemia survivors is important, especially among those with relapse, to detect and manage epilepsy early and mitigate its impact on quality of life.

Keywords: Case cohort study; Childhood cancer; Epilepsy; Late complications.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: This is an observational study. The study was originally approved by national or regional ethics committee or institutions: Denmark, the National Board of Health (j.nr. 3–3013-71/1/); Sweden, Regionala Etikprövningsnämnden, Lund (Dnr 2012/682); and Finland, National Institute for Health and Welfare (No. THL/1284/5.05.00/2013). The project is listed in a local archive (2019-DCRC-0055) at the Danish Cancer Institute, which provides an accurate, updated overview of ongoing projects and of ongoing research projects involving personal data under the GDPR. Competing interests: The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Oeffinger KC, Robison LL. Childhood cancer survivors, late effects, and a new model for understanding survivorship. JAMA. 2007;297:2762–4. https://doi.org/10.1001/jama.297.24.2762 . - DOI - PubMed
    1. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. NEnglJ Med. 2006;355:1572–82. - DOI
    1. Bhakta N, Liu Q, Ness KK, et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet. 2017;390:2569–82. https://doi.org/10.1016/S0140-6736(17)31610-0 . - DOI - PubMed - PMC
    1. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297:2705–15. - DOI - PubMed
    1. Norsker FN, Pedersen C, Armstrong GT, et al. Late effects in childhood cancer survivors: early studies, survivor cohorts, and significant contributions to the field of late effects. Pediatr Clin North Am. 2020;67:1033–49. https://doi.org/10.1016/j.pcl.2020.07.002 . - DOI - PubMed - PMC

LinkOut - more resources